premargin

Sign In Sign Upعربي

Astra Industrial Group announces its Interim Financial results for the Period Ending on 2026-03-31 ( Three Months ) | premargin

Element List	Current Quarter	Similar quarter for previous year	%Change	Previous Quarter	% Change
Sales/Revenue	790,909,047	833,728,170	-5.135	791,827,797	-0.116
Gross Profit (Loss)	385,259,335	372,598,003	3.398	368,859,731	4.446
Operational Profit (Loss)	192,085,715	189,301,115	1.47	119,688,569	60.487
Net Profit (Loss) Attributable to Shareholders of the Issuer	173,138,809	171,871,096	0.737	152,574,252	13.478
Total Comprehensive Income Attributable to Shareholders of the Issuer	172,515,689	176,723,126	-2.38	156,953,969	9.914
All figures are in (Actual) Saudi Arabia, Riyals

Element List	Current Period	Similar period for previous year	%Change
Total Shareholders Equity (after Deducting Minority Equity)	3,134,506,371	2,700,529,204	16.07
Profit (Loss) per Share	2.16	2.15
All figures are in (Actual) Saudi Arabia, Riyals

Element List	Amount	Percentage of the capital (%)
Profit (Losses) Resulting From The Change In Investment Propertie’s Fair Value	-	-
All figures are in (Actual) Saudi Arabia, Riyals

Element List	Explanation
The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the same quarter of the last year is	Revenue decreases in general due to: Decrease in revenue in the following segments: a) Steel Industry b) Specialty chemical. While noting that there is slight increase in revenue in pharmaceuticals segment.
The reason of the increase (decrease) in the net profit during the current quarter compared to the same quarter of the last year is	Net profit Increases in general due to: 1. Increase in Gross Profit in the following segments: a) Pharmaceuticals b) Steel Industry 2. Decrease in finance costs mainly in the following segments: a) Specialty Chemical b) Pharmaceuticals. While noting that there is decrease in other income, net in other segment.
The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the previous one is	Sales decrease in general due to: Decrease in sales in steel segment. While noting that there is increase in sales in the pharmaceuticals segment.
The reason of the increase (decrease) in the net profit (loss) during the current quarter compared to the previous one is	Net profit Increases in general due to: 1. Increase Gross Profit in Profit in the following segments: a. Pharmaceuticals b. Specialty chemical While noting that there is decrease in Gross Profit in Steel industries. 2. Decrease in General and administrative expenses in following sectors: a) Steel industries b) Specialty chemical 3. Decrease in Provision for impairment of financial assets expenses in following sectors: a) Steel industries b) Specialty chemical While noting that there is decrease in share in profit from unconsolidated subsidiary.
Statement of the type of external auditor's report	Unmodified conclusion
Comment mentioned in the external auditor’s report, mentioned in any of the following paragraphs (other matter, conservation, notice, disclaimer of opinion, or adverse opinion)	N\A
Reclassification of Comparison Items	Certain comparative figures for the previous period have been reclassified to be consistent with the presentation of the current period.
Additional Information	Net Shareholders’ Equity at the end of the period was SR 3,133,945,566/- compared to SR 2,707,857,633 /- at the end of the similar period last year with an increase of 16%.